Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe

Pardo-Cabello, Alfredo José; Manzano-Gamero, Victoria; Luna, Juan de Dios

doi:10.1016/j.ejim.2023.02.014

European Journal of Internal Medicine

2023

DOI: 10.1016/j.ejim.2023.02.014

|View full text |Cite

Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe

Alfredo José Pardo-Cabello

Victoria Manzano-Gamero

Juan de Dios Luna

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In one of the latest issues of the European Journal of Internal Medicine, Pardo-Cabello et al. [8] reviewed the EudraVigilance database to assess the ADRs reported among patients who received COVID-19 vaccines marketed in the EU. This is a valuable approach even if it is not possible to draw strong conclusions on the safety profile given the intrinsic limits of data obtained from surveillance post-marketing databases (i.e., retrospective enrolment, lack of denominator, risk of duplicated and risk of selection bias, etc.)…”

mentioning

confidence: 99%